[Active interventions in hypercholesteroloemia patients with high cardiovascular risk in primary care; estudio ESPROCOL].
| Autor: | Tárraga López PJ; Profesor Asociado de Medicina. Universidad Castilla-La Mancha.. pjtarraga@sescam.jccm.es., García-Norro Herreros FJ; Centro de Salud Condesa. Sacyl, León.. pjtarraga@sescam.jccm.es., Tárraga Marcos L; DUE Residencia Geriátrica Los Álamos de Albacete.. pjtarraga@sescam.jccm.es., Solera Albero J; Coordinador Médico Centro Salud Zona 7, Albacete.. pjtarraga@sescam.jccm.es., González López E; Centro de Salud Villanueva de la Cañada, Madrid.. pjtarraga@sescam.jccm.es., Ruiz García A; Centro de Salud Pinto, Madrid.. pjtarraga@sescam.jccm.es., Pallarés Carratalá V; Centro de Salud Vilarreal.. pjtarraga@sescam.jccm.es., Castro Navarro JL; Centro de Salud Munera, Albacete.. pjtarraga@sescam.jccm.es., Alins Presas J; Especialista Medicina Familiar y Comunitaria Area Básica de Salud Abrera.. pjtarraga@sescam.jccm.es., Panisello Royo JM; Jefe Medicina Interna Hospital Igualada, España.. pjtarraga@sescam.jccm.es. |
|---|---|
| Jazyk: | Spanish; Castilian |
| Zdroj: | Nutricion hospitalaria [Nutr Hosp] 2015 Jun 01; Vol. 31 (6), pp. 2727-34. Date of Electronic Publication: 2015 Jun 01. |
| DOI: | 10.3305/nh.2015.31.6.8998 |
| Abstrakt: | Introduction: Hypercholesterolemia is a major modifiable risk factors for cardiovascular disease (CVD). Its reduction reduces morbidity and mortality from ischemic heart disease and CVD in general, primary prevention and secondary prevention especially. Objective: To determine whether a notarized and intensive clinical practice can overcome inertia and achieve the therapeutic goal (OT) LDL-C <100 mg/dL in high-risk patients attended in Primary Care (PC) in our country. Methodology: Epidemiological, prospective, multicenter study conducted in centers of different ACs By AP consecutive sampling 310 patients at high cardiovascular risk (diabetic or established CVD) previously treated with statins, which did not reach the OT included c-LDL. Results: The study subjects had a mean age of 65.2 years, of which 60.32% were male. The 41.64% had a previous EVC, acute myocardial infarction (20.33%), angina (16.07%), stroke/TIA (9.19%), arthropathy (5.25%), diabetes (70.87%), hypertension (71.01%), and abdominal obesity (69.62%). The 43.57% (95% CI: 37,21; 50,08) of patients who performed the 2nd visit (241) got the OT. 62.50% (95% CI: 55.68, 68.98) of those who took the 3rd (216) got the OT. Finally, 77.56% (95% CI: 72.13, 83.08) patients who performed the last visit (205) got the OT. Throughout the study there was a reduction in LDL-C levels from 135.6 mg/dL at baseline, 107.4 mg dL in the 2nd visit, 97.3 mg/dL in the 3rd visit, up to 90.7 mg/dL at the final visit (p < 0.0001). The increase in HDL-C from baseline (50.9 mg/dL) and final (53.6 mg/dL) was also significant (p = 0.013). Conclusions: The reassessment and intensification of treatment in patients at high cardiovascular risk treated in primary care, applying the indications of the guides, achieves the OT in more than three quarters of the previously uncontrolled within half a year. These results should encourage us to overcome the therapeutic inertia in the control of CVD by early and energetic performance against hypercholesterolemia. (Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|